FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry, namely to an agent for tissue regeneration. Agent for tissue regeneration in the form of dosage forms containing auxiliary substances and cell mass of embryos tissues of birds and/or other animals carrying a receptor defined by specific monoclonal antibodies, as CD34 + phenotype cells, except for phenotype CD34 + CD45dim cells.
EFFECT: agent described above exhibits a marked regenerative, anti-inflammatory and antibacterial action.
1 cl, 15 dwg, 12 ex
Title | Year | Author | Number |
---|---|---|---|
CELLGEL WOUND HEALING PRODUCT, METHOD FOR PREPARING IT AND METHOD FOR HEALING OF WOUNDS OF VARIOUS AETHIOLOGIES BY PREPARED PRODUCT | 2011 |
|
RU2481115C1 |
METHOD OF OBTAINING PEPTIDES THAT INDUCE OWN STEM CELLS | 2022 |
|
RU2798876C1 |
WOUND HEALING OINTMENT FOR THE TREATMENT OF THERMAL BURNS | 2022 |
|
RU2787377C1 |
MEDICATION FOR TREATING BURNS AND WOUNDS BASED ON CYTOKINES AND GROWTH FACTORS, SECRETED BY MESENCHYMAL HUMAN CELLS, METHOD FOR THEREOF OBTAINING AND METHOD FOR TREATING BURNS AND WOUNDS | 2014 |
|
RU2574017C1 |
METHOD FOR TREATING FROSTBITE USING MESENCHYMAL STEM CELLS ISOLATED FROM RED BONE MARROW | 2020 |
|
RU2748539C1 |
COMPOSITION FOR CELL-REPLACEMENT THERAPY OF SOFT TISSUE DEFECTS | 2013 |
|
RU2522816C1 |
METHOD FOR DETERMINING SUBPOPULATION COMPOSITION OF SKIN CELLS AND OBTAINING SKIN CYTOIMMUNOGRAM | 2016 |
|
RU2630607C1 |
COMBINED GRAFT OF DERMAL MATRIX WITH MESENCHYMAL MULTIPOTENT STROMAL CELLS, METHOD FOR PREPARING IT AND METHOD FOR WOUND HEALING USING IT | 2013 |
|
RU2526813C1 |
MODEL OF HLA-INCOMPATIBLE HUMANIZED NSG MOUSE WITH XENOGRAFT OBTAINED FROM A PATIENT | 2016 |
|
RU2757421C2 |
CELL AND CELL EXTRACT INTRODUCTION FOR REJUVENATION | 2007 |
|
RU2421208C2 |
Authors
Dates
2019-11-25—Published
2018-08-31—Filed